McGray, A. J. R., Eppolito, C., Miliotto, A., Singel, K. L., Stephenson, K., Lugade, A., . . . Odunsi, K. (2021). A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer. Cancer Immunol Immunother.
Chicago Style CitationMcGray, A. J. R., et al. "A Prime/boost Vaccine Platform Efficiently Identifies CD27 Agonism and Depletion of Myeloid-derived Suppressor Cells As Therapies That Rationally Combine With Checkpoint Blockade in Ovarian Cancer." Cancer Immunol Immunother 2021.
Cita MLAMcGray, A. J. R., et al. "A Prime/boost Vaccine Platform Efficiently Identifies CD27 Agonism and Depletion of Myeloid-derived Suppressor Cells As Therapies That Rationally Combine With Checkpoint Blockade in Ovarian Cancer." Cancer Immunol Immunother 2021.